FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3208944503> ?p ?o ?g. }

• W3208944503 endingPage "101" @default.
• W3208944503 startingPage "90" @default.
• W3208944503 abstract "Peroxisome proliferator-activated receptor gamma (PPARγ) agonists are highly effective in treating insulin resistance. However, associated side effects such as weight gain due to increase in adipogenesis and lipogenesis hinder their clinical use. The aim of the study was to design and synthesize novel partial PPARγ agonists with weaker lipogenic effect in adipocytes and enhanced glucose transporter 4 (GLUT4) translocation stimulatory effect in skeletal muscle cells.Novel partial PPARγ agonists (GS1, GS2, and GS3) were designed and screened to predict their binding interactions with PPARγ by molecular docking. The stability of the docked ligand-PPARγ complex was studied by molecular dynamics (MD) simulation. The cytotoxicity of synthesized compounds was tested in 3T3-L1 adipocytes and L6 myoblasts by MTT assay. The lipogenic effect was investigated in 3T3-L1 adipocytes using oil red O staining and GLUT4 translocation stimulatory effect in L6-GLUT4myc myotubes by an antibody-coupled colorimetric assay.The molecular docking showed the binding interactions between designed agonists and PPARγ. MD simulation demonstrated good stability between the GS2-PPARγ complex. GS2 and GS3 did not show any significant effect on cell viability up to 80 or 100 μM concentration. Pioglitazone treatment significantly increased intracellular lipid accumulation in adipocytes compared to control. However, this effect was significantly less in GS2- and GS3-treated conditions compared to pioglitazone at 10 μM concentration, indicating weaker lipogenic effect. Furthermore, GS2 significantly stimulated GLUT4 translocation to the plasma membrane in a dose-dependent manner via the AMPK-dependent signaling pathway in skeletal muscle cells.GS2 may be a promising therapeutic agent for the treatment of insulin resistance and type 2 diabetes mellitus without adiposity." @default.
• W3208944503 created "2021-11-08" @default.
• W3208944503 creator A5004160294 @default.
• W3208944503 creator A5015805563 @default.
• W3208944503 creator A5020422994 @default.
• W3208944503 creator A5036270415 @default.
• W3208944503 creator A5042783687 @default.
• W3208944503 creator A5062421935 @default.
• W3208944503 date "2021-11-04" @default.
• W3208944503 modified "2023-10-14" @default.
• W3208944503 title "A Novel Partial PPARγ Agonist Has Weaker Lipogenic Effect in Adipocytes and Stimulates GLUT4 Translocation in Skeletal Muscle Cells via AMPK-Dependent Signaling" @default.
• W3208944503 cites W1981961082 @default.
• W3208944503 cites W1997867512 @default.
• W3208944503 cites W2005309870 @default.
• W3208944503 cites W2020723945 @default.
• W3208944503 cites W2021010709 @default.
• W3208944503 cites W2031532881 @default.
• W3208944503 cites W2035926347 @default.
• W3208944503 cites W2037546085 @default.
• W3208944503 cites W2053876364 @default.
• W3208944503 cites W2054277796 @default.
• W3208944503 cites W2059742529 @default.
• W3208944503 cites W2060079863 @default.
• W3208944503 cites W2078374645 @default.
• W3208944503 cites W2091469763 @default.
• W3208944503 cites W2127014382 @default.
• W3208944503 cites W2170764780 @default.
• W3208944503 cites W2197535902 @default.
• W3208944503 cites W2340270369 @default.
• W3208944503 cites W2736294384 @default.
• W3208944503 cites W2752702863 @default.
• W3208944503 cites W2765770941 @default.
• W3208944503 cites W2899206522 @default.
• W3208944503 cites W2899329923 @default.
• W3208944503 cites W2911830461 @default.
• W3208944503 cites W2936415103 @default.
• W3208944503 cites W816513525 @default.
• W3208944503 doi "https://doi.org/10.1159/000519331" @default.
• W3208944503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34736259" @default.
• W3208944503 hasPublicationYear "2021" @default.
• W3208944503 type Work @default.
• W3208944503 sameAs 3208944503 @default.
• W3208944503 citedByCount "2" @default.
• W3208944503 countsByYear W32089445032022 @default.
• W3208944503 countsByYear W32089445032023 @default.
• W3208944503 crossrefType "journal-article" @default.
• W3208944503 hasAuthorship W3208944503A5004160294 @default.
• W3208944503 hasAuthorship W3208944503A5015805563 @default.
• W3208944503 hasAuthorship W3208944503A5020422994 @default.
• W3208944503 hasAuthorship W3208944503A5036270415 @default.
• W3208944503 hasAuthorship W3208944503A5042783687 @default.
• W3208944503 hasAuthorship W3208944503A5062421935 @default.
• W3208944503 hasConcept C104317684 @default.
• W3208944503 hasConcept C11960822 @default.
• W3208944503 hasConcept C122927707 @default.
• W3208944503 hasConcept C126322002 @default.
• W3208944503 hasConcept C134018914 @default.
• W3208944503 hasConcept C138626823 @default.
• W3208944503 hasConcept C161573976 @default.
• W3208944503 hasConcept C170493617 @default.
• W3208944503 hasConcept C171089720 @default.
• W3208944503 hasConcept C185592680 @default.
• W3208944503 hasConcept C187345961 @default.
• W3208944503 hasConcept C2776188179 @default.
• W3208944503 hasConcept C2777180221 @default.
• W3208944503 hasConcept C2777866211 @default.
• W3208944503 hasConcept C2778384471 @default.
• W3208944503 hasConcept C2778938600 @default.
• W3208944503 hasConcept C2779306644 @default.
• W3208944503 hasConcept C2780124434 @default.
• W3208944503 hasConcept C55493867 @default.
• W3208944503 hasConcept C555293320 @default.
• W3208944503 hasConcept C71924100 @default.
• W3208944503 hasConcept C86803240 @default.
• W3208944503 hasConcept C97029542 @default.
• W3208944503 hasConceptScore W3208944503C104317684 @default.
• W3208944503 hasConceptScore W3208944503C11960822 @default.
• W3208944503 hasConceptScore W3208944503C122927707 @default.
• W3208944503 hasConceptScore W3208944503C126322002 @default.
• W3208944503 hasConceptScore W3208944503C134018914 @default.
• W3208944503 hasConceptScore W3208944503C138626823 @default.
• W3208944503 hasConceptScore W3208944503C161573976 @default.
• W3208944503 hasConceptScore W3208944503C170493617 @default.
• W3208944503 hasConceptScore W3208944503C171089720 @default.
• W3208944503 hasConceptScore W3208944503C185592680 @default.
• W3208944503 hasConceptScore W3208944503C187345961 @default.
• W3208944503 hasConceptScore W3208944503C2776188179 @default.
• W3208944503 hasConceptScore W3208944503C2777180221 @default.
• W3208944503 hasConceptScore W3208944503C2777866211 @default.
• W3208944503 hasConceptScore W3208944503C2778384471 @default.
• W3208944503 hasConceptScore W3208944503C2778938600 @default.
• W3208944503 hasConceptScore W3208944503C2779306644 @default.
• W3208944503 hasConceptScore W3208944503C2780124434 @default.
• W3208944503 hasConceptScore W3208944503C55493867 @default.
• W3208944503 hasConceptScore W3208944503C555293320 @default.
• W3208944503 hasConceptScore W3208944503C71924100 @default.
• W3208944503 hasConceptScore W3208944503C86803240 @default.
• W3208944503 hasConceptScore W3208944503C97029542 @default.

• next